Protein Metrics Inc. Announces Fourth Year of Record Growth
January 4, 2018
SAN CARLOS, Calif. -- Protein Metrics Inc., a premier provider of mass spectrometry software for protein characterization, announces a fourth consecutive year of record revenue and bookings. Sales of products more than doubled from 2016. Growth was evenly distributed between renewals of licenses to existing customers, expansion of products and users within existing customer organizations, and [...]
January 4, 2018
Companies Target Review Aimed at Molecular Oncology and Hereditary Diseases SAN DIEGO--Illumina, Inc. (NASDAQ: ILMN) and KingMed Diagnostics (SSE: 603882.SS) today announced an agreement to jointly develop novel oncology and hereditary disease testing applications utilizing Illumina's next-generation sequencing (NGS) technology. The collaboration is a significant step toward China Food and Drug Administration (CFDA) review and approval, and serves as a [...]
HORIBA Scientific Integrates AIST-NT’S Scanning Probe Microscopy Technology
January 4, 2018
Raman capabilities now range from micro- to NanoRaman and provides entry into the SPM market After four years of successful cooperation with AIST-NT, HORIBA Scientific, a global leader in Raman spectroscopy for over 50 years, announced the acquisition of AIST-NT technology. This technology will strengthen HORIBA’s leadership in NanoRaman spectroscopy by combining the most advanced [...]
January 4, 2018
SEATTLE and TOKYO -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and Riken Genesis, a subsidiary of Sysmex Corporation (TOKYO, 6869), today announced that they have entered into a partnership to introduce nCounter-based diagnostic assays in Japan. Under this agreement, NanoString and Riken Genesis will collaborate to register, obtain reimbursement and [...]
BERKELEY LIGHTS ANNOUNCES RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH PFIZER
January 4, 2018
Emeryville, Calif. – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today that it has entered into a research collaboration and license agreement with Pfizer Inc. (NYSE: PFE) focused on optimizing BLI’s proprietary BeaconTMOptofluidic platform with the goal of helping to accelerate Pfizer’s monoclonal antibody (mAb) [...]
January 3, 2018
Innsbruck, Austria – BIOCRATES Life Sciences AG, a global leader in targeted metabolomics, announced today the acquisition of Metanomics Health GmbH. Metanomics Health is a metabolomics biomarker development and healthcare services specialist based in Berlin, Germany. At the same time, the company is closing a significant financing round to support future growth. BASF Plant Science GmbH, [...]
Asynt Announces Chemistry Tools Innovation Service
January 3, 2018
Asynt announces “Asyntise” a consultation, design and manufacture service whereby the company collaborates with scientists to create practical tools to help fulfil their research needs. These products may be in the form of one-off custom developments or, in some instances, may evolve into a commercial product suitable for a wider audience. Asyntise formalises the close [...]
Elementar invests in new headquarters for Americas subsidiary
January 3, 2018
New corporate facility in Ronkonkoma, New York In March 2018, Elementar will open a new corporate facility in Ronkonkoma, New York. The relocation to Ronkonkoma marks a new chapter in the history of Elementar Americas which started 20 years ago in Mount Laurel, New Jersey. Serving as the headquarters for the Americas business, the building [...]
BGI Accelerator Global Recruitment
January 3, 2018
Founded in 1999,and with the vision of using genomics to benefit mankind,BGI has since become the largest genomic organization in the world. With the rapid development of genetic testing, BGI, the industry pioneer, is willing to work together with innovators around the world to unlock the power of genome,by building an open biological research, transformation and [...]
January 3, 2018
Burlingame, California — Collaborative Drug Discovery, provider of CDD Vault® web-based drug discovery informatics platform, announced they have been awarded a $1.5M Phase 2B SBIR grant titled “Comprehensive but simple encoding of bioassays to accelerate translational drug discovery”. These innovations are productized in the commercially available collaborative CDD Vault ELN (Electronic Laboratory Notebook) and a new, intelligent [...]

